When you bring a piece of chocolate to your mouth, your brain responds by giving you a flood of dopamine, a chemical associated with pleasure — but that’s not dopamine’s only function. Local researchers think it may also play an important role in how the brain processes sound and communications.
Prions, the protein family notorious for causing “mad cow” and neurodegenerative diseases like Parkinson’s, can play an important role in healthy cells. “Do you think God created prions just to kill?” mused Nobel laureate Eric Kandel. “These things must have evolved initially to have a physiological function.” His work on memory helped reveal that animals make and use prions in their nervous systems as part of an essential function: stabilizing the synapses that constitute long-term memories.
(NaturalNews) Is it possible that the simple act of drinking green tea can help protect your brain against Parkinson’s and Alzheimer’s disease? A multitude of studies have looked into the effects that the tea has on neurological health — and the results are promising.
Ezose Sciences Inc. today announced that it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research to apply Ezose’s GlycanMap® technology to investigating the role of the sugars known as glycans in Parkinson’s disease.
As medical researchers across disease states pursue better treatments, they all share one limiting factor. Estimates hold that 85 percent of all studies face delays and 30 percent never get off the ground due to a lack of clinical research volunteers. Slow patient enrollment diminishes the scientific power of studies, drives costs up and, most notably, delays improved therapies for patients.
A Dutch life science startup is collaborating with biotechnology companies to make it easier for patients with advanced chronic conditions and unable to get into clinical trials to access potentially life-saving drugs before they are cleared by regulators. MyTomorrows positions itself as a patient-focused company and recently raised $2.2 million from friends and family to expand the treatments available for this program to include amyotrophic lateral sclerosis or Lou Gehrig’s disease, multiple sclerosis and Parkinson’s disease, among others.
A New Zealand biotech company’s world-first trial injecting pig cells into human brains has been stopped after researchers were unable to confirm findings in their initial studies on rats.
Maria Caruso considers Bodiography Contemporary Ballet more than a dance group. It’s a platform for social activism. For the past few years, she’s used her choreography to tell people’s stories of trumping personal obstacles, including heart transplants and children’s experiences with grief.
“If I can share the beauty of humanity and make the world a more tolerable place, a more compassionate place … then I feel I’ve really achieved my goals,” Ms. Caruso says.
The U.S. Food and Drug Administration today approved Northera capsules (droxidopa) for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating drop in blood pressure upon standing that is associated with Parkinson’s disease, multiple-system atrophy, and pure autonomic failure.
VANCOUVER, British Columbia, Feb. 18 (UPI) – The mind can help the body heal. Scientists have known this for several decades, as study after study has demonstrated the power of a sugar pill to mitigate problems like pain and depression. But new research suggests a placebos can even help relieve the symptoms of a serious neurological disorder, like Parkinson’s disease.
There is no known cure for Parkinson’s disease in the world today. At any rate, not yet. Doctors say the goal of treatment is to control the symptoms, but some specialists claim when symptoms start appearing, a cure is already impossible. Understandably, the early diagnostics of Parkinson’s disease is vitally important.